Global Anastomosis Devices Market Insights Forecasts to 2032

• The Global Anastomosis Devices Market Size was valued at USD 3.45 Billion in 2022.
• The Market is growing at a CAGR of 5.7% from 2022 to 2032.
• The Worldwide Anastomosis Devices Market Size is expected to reach USD 6.01 Billion by 2032.
• Asia-Pacific is expected to grow higher during the forecast period.

 

Get more details on this report -

Request Free Sample PDF

The Global Anastomosis Devices Market Size is expected to reach USD 6.01 Billion by 2032, at a CAGR of 5.7% during the forecast period 2022 to 2032.

 

Market Overview

Anastomosis devices play a crucial role in modern surgical procedures by facilitating the connection of blood vessels, intestines, and other tubular structures in a safe and efficient manner. These devices are designed to ensure secure and precise anastomoses, enabling better patient outcomes and reduced complications. Various types of anastomosis devices are available, including staplers, clips, sutures, and vascular connectors. Staplers offer fast and consistent closure, while clips and sutures provide flexibility for delicate tissues. Vascular connectors aid in creating seamless connections in vascular surgeries. The development of innovative anastomosis devices has revolutionized surgical practices, promoting quicker procedures and post-operative recoveries, making them indispensable tools for surgeons across a wide range of medical specialties.

 

Report Coverage

This research report categorizes the market for anastomosis devices market based on various segments and regions and forecasts revenue growth and analyzes trends in each submarket. The report analyses the key growth drivers, opportunities, and challenges influencing the anastomosis devices market. Recent market developments and competitive strategies such as expansion, product launch, and development, partnership, merger, and acquisition have been included to draw the competitive landscape in the market. The report strategically identifies and profiles the key market players and analyses their core competencies in each sub-segments of the anastomosis devices market.

 

Driving Factors

The anastomosis devices market is driven by several factors that contribute to its growth and expansion. One of the primary drivers is the increasing prevalence of chronic diseases and conditions, such as cardiovascular diseases, gastrointestinal disorders, and cancer. As these conditions often require surgical interventions that involve anastomosis, the demand for these devices rises proportionally. Advancements in surgical techniques and medical technologies also play a significant role in driving the market. The development of minimally invasive surgeries has led to a surge in demand for specialized anastomosis devices that can be used in laparoscopic and robotic-assisted procedures. These devices offer benefits such as reduced surgical trauma, shorter hospital stays, and faster recovery times, which appeal to both patients and healthcare providers. Furthermore, the aging population contributes to the growth of the anastomosis devices market. As the elderly are more susceptible to various diseases requiring surgical intervention, the demand for anastomosis devices increases accordingly. Moreover, government initiatives and favorable reimbursement policies in many countries encourage the adoption of advanced medical devices, including anastomosis devices. This, in turn, stimulates market growth by making these devices more accessible to healthcare facilities and patients. Additionally, rising healthcare expenditure in both developed and developing economies fuels the demand for advanced surgical procedures and medical devices, including anastomosis devices. Overall, the combination of increasing disease prevalence, technological advancements, demographic trends, government support, and healthcare expenditure drives the growth and expansion of the global anastomosis devices market.

 

Restraining Factors

The anastomosis devices market also faces certain restraints that may hinder its growth. One significant restraint is the high cost associated with these devices and their surgical procedures. The expenses involved can be a deterrent for patients and healthcare providers, particularly in regions with limited financial resources. Additionally, the complexity of using some advanced anastomosis devices may require specialized training, which could lead to slower adoption rates. Furthermore, the potential risks and complications associated with anastomosis procedures may also contribute to hesitancy among patients and healthcare professionals.

 

Market Segmentation

• In 2022, the disposable segment accounted for around 75.4% market share

On the basis of the product type, the global anastomosis devices market is segmented into disposable and reusable. The disposable segment has secured the largest revenue share in the anastomosis devices market due to several factors. Disposable anastomosis devices offer convenience, reduced risk of cross-contamination, and eliminate the need for sterilization and reprocessing costs. They are particularly favored in healthcare settings where infection control is critical. Additionally, disposable devices are often more cost-effective for healthcare facilities, as they do not require significant upfront investments and can be billed separately for each procedure.

 

• The cardiovascular surgery segment held the largest market in 2022, revenue share of around 47.5%

Based on the application, the global anastomosis devices market is segmented into cardiovascular surgery, gastrointestinal surgery, and others. The cardiovascular surgery segment has emerged as the largest market in the anastomosis devices market due to several factors. Cardiovascular diseases, such as coronary artery disease and heart valve disorders, are prevalent worldwide, leading to high demand for surgical interventions. Anastomosis devices play a crucial role in cardiovascular surgeries, facilitating secure connections of blood vessels and grafts. The increasing prevalence of cardiovascular conditions, coupled with advancements in surgical techniques and the adoption of innovative anastomosis devices, has significantly boosted the demand for these devices in cardiovascular surgery.

 

• The ambulatory care centers & clinics segment is expected to grow at a CAGR of around 5.8% during the forecast period

Based on the type of end-user, the global anastomosis devices market is segmented into hospitals and ambulatory care centers & clinics. The ambulatory care centers & clinics segment is expected to experience the fastest expansion in the anastomosis devices market during the forecast period due to several factors. With the increasing focus on cost-effective healthcare services and a shift towards outpatient care, ambulatory care centers and clinics are gaining popularity. These facilities offer convenient and efficient treatment options for patients, including surgical procedures that involve anastomosis devices. The rising number of outpatient surgeries performed in these centers, coupled with advancements in surgical techniques and medical devices, contribute to the segment's rapid growth, making it a key driver in the overall market expansion

 

Regional Segment Analysis of the Anastomosis Devices Market

• North America (U.S., Canada, Mexico) 
• Europe (Germany, France, U.K., Italy, Spain, Rest of Europe)
• Asia-Pacific (China, Japan, India, Rest of APAC)
• South America (Brazil and the Rest of South America) 
• The Middle East and Africa (UAE, South Africa, Rest of MEA)

 

North America dominated the market with more than 44.6% revenue share in 2022.

Get more details on this report -

Request Free Sample PDF

North America has emerged as the leading revenue contributor in the anastomosis devices market due to the advanced healthcare infrastructure, high healthcare expenditure, and increasing prevalence of chronic diseases drive the demand for surgical interventions involving anastomosis devices. Moreover, North America is at the forefront of adopting innovative medical technologies and surgical techniques, which further stimulates the market's growth. Additionally, favorable reimbursement policies and government support for medical advancements in the region provide a conducive environment for the widespread use of anastomosis devices, consolidating North America's position as the largest revenue-generating market in this domain.

 

Asia Pacific (APAC) is projected to experience the highest growth in the anastomosis devices market over the forecast period. The region's large and growing population, increasing prevalence of chronic diseases, improving healthcare infrastructure, and rising disposable income levels are key factors driving the demand for surgical procedures involving anastomosis devices. Additionally, expanding medical tourism and government initiatives to enhance healthcare facilities further contribute to the region's market growth.

 

Competitive Analysis:

The report offers the appropriate analysis of the key organizations/companies involved within the global anastomosis devices market along with a comparative evaluation primarily based on their product offering, business overviews, geographic presence, enterprise strategies, segment market share, and SWOT analysis. The report also provides an elaborative analysis focusing on the current news and developments of the companies, which includes product development, innovations, joint ventures, partnerships, mergers & acquisitions, strategic alliances, and others. This allows for the evaluation of the overall competition within the market.

 

List of Companies:

• Medtronic
• LivaNova PLC
• MAQUET Holding B.V. & Co. KG.
• Dextera Surgical Inc.
• Vitalitec Internaional Inc.
• Synovis Micro Companies Alliance, Inc.
• Ethicon, LLC
• Peters Surgical
• Meril Life Sciences Pvt. Ltd.
• Intuitive Surgical Inc.

 

Key Target Audience

• Market Players
• Investors
• End-Users
• Government Authorities 
• Consulting and Research Firm
• Venture Capitalists
• Value-Added Resellers (VARs)

 

Recent Developments

• In January 2022, Seger Surgical Solutions has begun work on a next-generation laparoscopic bowel closure device for intracorporeal anastomosis (IA). The novel LAP IA 60 device can align, close, and staple typical openings for intracorporeal anastomosis rapidly, securely, and without the need for suturing.

 

• In March 2021, The FDA granted Vascular Graft Solutions Ltd. marketing authorization for VIOLA. This is a revolutionary clampless proximal anastomosis device for coronary artery bypass grafts.

 

Market Segment

This study forecasts revenue at global, regional, and country levels from 2019 to 2032. Spherical Insights has segmented the global anastomosis devices market based on the below-mentioned segments:

 

Anastomosis Devices Market, By Product Type

• Disposable
• Reusable

 

Anastomosis Devices Market, By Application

• Cardiovascular Surgery
• Gastrointestinal Surgery
• Others

 

Anastomosis Devices Market, By End-User

• Hospitals
• Ambulatory Care Centers & Clinics

 

Anastomosis Devices Market, Regional Analysis

• North America
  • US
  • Canada
  • Mexico
• Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Russia
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Rest of Asia Pacific
• South America
  • Brazil
  • Argentina
  • Rest of South America
• Middle East & Africa
  • UAE
  • Saudi Arabia
  • Qatar
  • South Africa
  • Rest of Middle East & Africa